Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement
Saba, L.; Brinjikji, W.; Spence, J. D.; Wintermark, M.; Castillo, M.; de Borst, G. J. D.; Yang, Q.; Yuan, C.; Buckler, A.; Edjlali, M.; Saam, T.; Saloner, D.; Lal, B. K.; Capodanno, D.; Sun, J.; Balu, N.; Naylor, R.; Lugt, A. V. D.; Wasserman, B. A.; Kooi, M. E.; Wardlaw, J.; Gillard, J.; Lanzino, G.; Hedin, U.; Mikulis, D.; Gupta, A.; DeMarco, J. K.; Hess, C.; Goethem, J., V; Hatsukami, T.; Rothwell, P.; Brown, M. M.; Moody, A. R.
(2021) American Journal of Neuroradiology, volume 42, issue 9, pp. 1566 - 1575
(Article)
Abstract
Current guidelines for primary and secondary prevention of stroke in patients with carotid atherosclerosis are based on the quantification of the degree of stenosis and symptom status. Recent publications have demonstrated that plaque morphology and composition, independent of the degree of stenosis, are important in the risk stratification of carotid
... read more
atherosclerotic disease. This finding raises the question as to whether current guidelines are adequate or if they should be updated with new evidence, including imaging for plaque phenotyping, risk stratification, and clinical decision-making in addition to the degree of stenosis. To further this discussion, this roadmap consensus article defines the limits of luminal imaging and highlights the current evidence supporting the role of plaque imaging. Furthermore, we identify gaps in current knowledge and suggest steps to generate high-quality evidence, to add relevant information to guidelines currently based on the quantification of stenosis.
show less
Download/Full Text
Keywords: Radiology Nuclear Medicine and imaging, Clinical Neurology
ISSN: 0195-6108
Publisher: American Society of Neuroradiology
Note: Funding Information: Disclosures: Mauricio Castillo—UNRELATED: Employment: University of North Carolina. Peter Rothwell—UNRELATED: Board Membership: ARRIVE Trial Executive Committee; Consultancy: BMS Axiomatic Trial Data and Safety Monitoring Board; Payment for Lectures Including Service on Speakers Bureaus: Abbott for lecture on Patent Forame Ovale closure; Other: lecture on TIA for AstraZeneca. Max Wintermark—UNRELATED: Consultancy: Magnetic Insight, Subtle Medical, EMTensor, Icometrix, Nous Infosystems. Chun Yuan—UNRELATED: Grants/Grants Pending: National Institutes of Health, American Heart Association, Philips Healthcare.* Andrew Buckler—UNRELATED: Employment: Elucid Bioimaging. Davide Capod-anno—UNRELATED: Board Membership: Medtronic, Comments: speaker’s fee; Consultancy: BIOTRONIK, Comments: speaker’s fee; Employment: Boston Scientific, Comments: speaker’s fee; Expert Testimony: Daiichi Sankyo, Comments: speaker’s fee; Grants/Grants Pending: Boehringer Ingelheim, Comments: speaker’s fee; Payment for Lectures Including Service on Speakers Bureaus: Bayer AG, Comments: speaker’s fee; Payment for Manuscript Preparation: AstraZeneca, Comments: speaker’s fee. Ulf Hedin—UNRELATED: Employment: Karolinska Hospital; Grants/Grants Pending: Swedish Research Council. Waleed Brinjikji—UNRELATED: Consultancy: MicroVention, Cerenovus*; Stock/Stock Options: Marblehead Medical LLC. Thomas Hatsukami—UNRELATED: Grants/Grants Pending: investigator-initiated grant from Philips Healthcare, completed December 31, 2018.* Christopher Hess—UNRELATED: Personal Fees: GE Healthcare, Focused Ultrasound Foundation, uniQure, Comments: consultant for GE Healthcare and Data and Safety Monitoring Board member for Focused Ultrasound Foundation and uniQure; Nonfinancial Support: Siemens, Comments: research travel. Bruce A. Wasserman—UNRELATED: Grants/Grants Pending: National Institutes of Health R01.* Joanna Wardlaw—RELATED: Grant: National Institute for Health Research Health Technology Assessment Panel, Comments: funded the research.* Ajay Gupta—UNRELATED: Consultancy: ERT; Travel/Accommodations/Meeting Expenses Unrelated to Activities Listed: Siemens, GE Healthcare. Jie Sun—UNRELATED: Grants/Grants Pending: American Heart Association, Institute of Translational Health Sciences.* Niranjan Balu—UNRELATED: Patents (Planned, Pending or Issued): I hold a US patent 9,557,396 but no payment/ royalties. *Money paid to the institution. Publisher Copyright: © 2021 American Society of Neuroradiology. All rights reserved.
(Peer reviewed)